Protagonist Therapeutics (PTGX) Enterprise Value Growth (5y) (2020 - 2026)
Protagonist Therapeutics (PTGX) Enterprise Value Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Protagonist Therapeutics | 8.88 Bn | 8.88 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.91% |
| Dec 31, 2025 | -13.16% |
| Sep 30, 2025 | -47.10% |
| Jun 30, 2025 | -31.29% |
| Mar 31, 2025 | -56.99% |
| Dec 31, 2024 | -66.22% |
| Sep 30, 2024 | -56.33% |
| Jun 30, 2024 | -51.29% |
| Mar 31, 2024 | -35.71% |
| Dec 31, 2023 | -32.95% |
| Sep 30, 2023 | -29.69% |
| Jun 30, 2023 | -37.45% |
| Mar 31, 2023 | -27.10% |
| Dec 31, 2022 | -17.49% |
| Sep 30, 2022 | -39.62% |
| Jun 30, 2022 | -63.29% |
| Mar 31, 2022 | -100.06% |
| Dec 31, 2021 | -73.00% |
| Sep 30, 2021 | -26.76% |
| Jun 30, 2021 | -69.48% |